Literature DB >> 6233299

Analysis of T regulator cell surface markers and functional properties in multiple sclerosis.

J P Antel, D M Peeples, A T Reder, B G Arnason.   

Abstract

The relative proportions as well as cell surface and functional properties of T suppressor (T8+) and T helper (T4+) cells in peripheral blood mononuclear cells ( MNCs ) of MS patients were analyzed. The proportion of T8 cells compared to normal controls was suggestively lower in patients during relapses and significantly lower in those with progressive disease. The density of T8+ antigen on cells of MS patients with active disease as measured by median fluorescence intensity ( MFI ) was also decreased compared to controls and stable MS patients. Using OKT8-mAb modulated MNCs as a model, we found that reduction of T8 antigen density results in substantial discrepancies between FACS and microscope methods for enumeration of T8+ cells. Levels of pokeweed mitogen-induced IgG secretion by MNCs of MS patients did not correlate with proportion of T8+ cells within the MNCs , but rather with the functional activity of the T8+ cells of given individuals, as tested in an in vitro suppressor assay using constant numbers of T8+ cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233299     DOI: 10.1016/0165-5728(84)90030-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

Review 2.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Evidence for a missed signal to the CD8+ cells in CSF of multiple sclerosis patients.

Authors:  M Saresella; A Grope; L Speciale; R Mancuso; R De Benedictis; D Caputo; P Ferrante
Journal:  Ital J Neurol Sci       Date:  1995-10

4.  Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression?

Authors:  A Salmaggi; A Dufour; M Eoli; E Corsini; L La Mantia; G Massa; A Nespolo; C Milanese
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

5.  Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis.

Authors:  S Ferla; G Meneghetti; S Spartà; M Belloni; G Ongaro
Journal:  Ital J Neurol Sci       Date:  1985-09

6.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.

Authors:  M B Bania; J P Antel; A T Reder; M K Nicholas; B G Arnason
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

8.  Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse?

Authors:  A J Thompson; J Brazil; C A Whelan; E A Martin; M Hutchinson; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

Review 9.  The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.

Authors:  Michael P Pender
Journal:  Neuroscientist       Date:  2010-11-12       Impact factor: 7.519

10.  Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.

Authors:  Michael P Pender; Peter A Csurhes; Casey M M Pfluger; Scott R Burrows
Journal:  BMC Neurol       Date:  2011-08-03       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.